1
Bridging Medicine, Wellness, and Community – Part 1
2
Shared Insights on Treating BRAFV600-mutant Metastatic Cancers
3
Bonus Episode: c-Met Protein Overexpression as an Emerging Biomarker in NSCLC
4
Navigating the COVID-19 Vaccination Landscape: The Post-Pandemic Era
5
Congress Wrap: ESMO 2024
On-Demand Treatment Gaps in HAE
ESC 2024 Interview: Lis Neubeck
Dupilumab Offers Benefits in Bullous Pemphigoid Management
Interview: Philippe Froguel
Lord Darzi’s report on the NHS: What pharma needs to know
Lebrikizumab▼: Short and Long-Term Disease Control in Moderate-to-Severe AD Through Selective IL-13 Inhibition
Endoscopic Submucosal Dissection Effective for Colitis-Associated Neoplasia
Forecasting Tobacco-Free Generations by 2050
Stroke Risk Rises in Children with Sickle Cell Disease
New Guidelines for Metabolic Dysfunction-Associated Steatotic Liver Disease Management
Novel Sleeve Reduces Skin Damage with Axillary Osmidrosis Surgery
EMJ Interventional Cardiology 12.1 2024
New Antibody Target in Marburg Virus: Vaccine Potential
High Pulse Pressure Linked to Kidney Failure Risk in Patients with Diabetes
The Unspeakable Disease: A Tale of Two Siblings
ESMO 2024 Interview: Jianjun Zhang
AI Model Predicts Mortality Using Chest CT Findings
“Did you know” 2024 Video Podcast Series
Understanding COPD Outcomes for Women in Rural America: CHEST 2024
Advanced Imaging Techniques to Transform Arthritis Diagnosis
The Androgen Deprivation Therapy Landscape in 2024 – Co-navigating the Available Options with Prostate Cancer Patients